HHS Secretary Kennedy, after firing every member of key CDC vaccine advisory panel, appoints eight new members, including critics of mRNA technology.
Study on autism causes clouded by unusual funding mechanism, short timeline, researcher concerns on political influence, possible pre-determined conclusion.
Addiction was once a marquee issue for Kennedy and remains a top U.S. health crisis. Deep cuts to HHS treatment programs worry recovery advocates.
Systematic reviews, growing in popularity, can include retracted papers, low-quality research. Can a new AI tool help?
Kennedy’s dismissal of all the members of the CDC’s vaccine advisory committee, and the rapid hiring of eight replacements, could easily misfire.
The onetime competitor in the Covid-19 vaccine race see a "shared commitment" to the potential of mRNA technology.
America’s often conservative-voting rural communities will face the perfect storm if the big but not-so-beautiful bill is signed into law.
In this week's edition of "Adam's Biotech Scorecard," Adam also asked whether Regeneron's troubles are in the rearview mirror.